New TB Vaccine Safety Study in Healthy Adults
Part of Infections clinical trials.
This study tests a new tuberculosis vaccine called Lipovaxin in healthy adults aged 18–40. Researchers want to see if it is safe and how the body responds to it, which could help prevent TB infection in the future.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 40 years old and in good health
- You have no current or past tuberculosis infection or TB treatment
- Your blood work and urine tests show normal results
- You are not pregnant, breastfeeding, or planning to become pregnant during the study
- You have not received any other vaccines in the month before starting this study
- You do not have serious health conditions like advanced cancer, heart failure, autoimmune disease, or HIV
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study measures how strongly your immune system responds to COVID-19 vaccines. It includes people with newly diagnosed tuberculosis and a healthier comparison group, aiming to understand vaccine immune effects and safety.
This Phase 2 study tests MTBVAC, a TB vaccine candidate, to see if it is safe and whether it helps the immune system. It may be a fit if you’re eligible for TB and HIV-related vaccine safety testing and can follow study visits and testing.
This study tests new, faster ways to diagnose tuberculosis (TB) using samples like sputum (mucus from your lungs), tongue swabs, and urine. It aims to see if these new tests can find TB more accurately than current methods, which could help you get the right treatment sooner.
This trial tests a new skin test (EEC) to see if it can accurately detect tuberculosis infection in people aged 3 and older. It compares the test's results in healthy people, people with TB, and people with other lung diseases to check how well it works.
This study tests whether adding the cholesterol drug atorvastatin to standard TB treatment helps people recover faster. It is for people with newly diagnosed, drug-sensitive tuberculosis who have not yet started treatment.
This study tests personalized TB treatment schedules based on your individual risk factors. Researchers want to see if matching treatment intensity to your specific situation helps cure TB while minimizing side effects.
Hear when a new Tuberculosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.